PostCOVID Erişkin Moyamoya Olgusunda Anestezi Yönetimi

Authors

Fatma Özdemir
Fatma Çiğdem Ulus
Ülkü Aygen Türkmen

Synopsis

This case report presents the perioperative anesthetic management of Moyamoya disease in a 25-year-old female patient who had a history of COVID-19 infection two months prior, which was thought to have triggered or accelerated the disease. The patient, presenting with intraventricular hemorrhage and a leaking external ventricular drain, underwent craniotomy and multiple burr-hole revascularization surgery. Evaluated as ASA 1 with a Mallampati score of 1, she received midazolam premedication, while anesthesia was maintained using sevoflurane and remifentanil. To preserve optimal cerebral perfusion and hemodynamic stability, depth of anesthesia was monitored via Bispectral Index (BIS), mean arterial pressure was maintained in a normotensive range (85–100 mmHg), and strict control of normocarbia and normothermia was maintained. Following multimodal analgesia and ondansetron administration, the patient was extubated without complications, transferred to the intensive care unit, and discharged to the neurosurgery ward after two days of monitoring. The primary goal of anesthetic management in Moyamoya patients is to maintain the balance between cerebral oxygen supply and demand by strictly ensuring normotension, normocarbia, normothermia, and euvolemia.

References

Burke GM, Burke AM, Sherma AK, et al. Moyamoya disease: a summary. Neurosurg Focus. 2009;26(4):E11.

Mesiwala AH, Sviri G, Fatemi N, et al. Long-term outcome of superficial temporal artery-middle cerebral artery bypass for patients with moyamoya disease in the US. Neurosurg Focus. 2008;24(2):E15

Roder C, Nayak NR, Khan N, et al. Genetics of Moyamoya disease. J Hum Genet. 2010;55(11):711-716

Zhang H, Zheng L, Feng L. Epidemiology, diagnosis and treatment of moyamoya disease. Exp Ther Med. 2019;17(3):1977-1984

Kainth D, Chaudhry SA, Kainth H, et al. Epidemiological and clinical features of moyamoya disease in the USA. Neuroepidemiology. 2013;40(4):282-287.

Dlamini N, Muthusami P, Amlie-Lefond C. Childhood moyamoya: looking back to the future. Pediatr Neurol. 2019;91:11-19.

Gattinoni L, Chiumello D, Rossi S. COVID-19 pneumonia: ARDS or not? Crit Care. 2020 Apr 16;24(1):154. doi: 10.1186/s13054-020-02880-z.

Carod-Artal FJ. Neurological complications of coronavirus and COVID-19. Rev Neurol. 2020 May 1;70(9):311-322.

Chow CCN, Magnussen J, Ip J, et al. Acute transverse myelitis in COVID-19 infection. BMJ Case Rep. 2020 Aug 11;13(8):e236720. doi: 10.1136/bcr-2020-236720.

Munz M, Wessendorf S, Koretsis G, et al. Acute transverse myelitis after COVID-19 pneumonia. J Neurol. 2020 Aug;267(8):2196-2197.

Iba T, Connors JM, Levy JH. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm Res. 2020 Dec;69(12):1181-1189.

Butterworth JF, Mackey DC, Wasnick JD. Morgan and Mikhail Klinik Anesteziyoloji. (F. Handan Cuhruk, Çev. Ed.). Ankara: Güneş Kitap Evi, 2015.

Oliveira CR, Bernardo WM, Nunes VM. Benefit of general anesthesia monitored by bispectral index compared with monitoring guided only by clinical parameters. Systematic review and meta-analysis. Braz J Anesthesiol. 2017 Jan-Feb;67(1):72-84.

Adachi K, Yamamoto Y, Kameyama E, et al. [Early postoperative complications in patients with Moyamoya disease--a comparison of inhaled anesthesia with total intravenous anesthesia (TIVA)]. Masui. 2005 Jun;54(6):653-7. Japanese.

Sato K, Shirane R, Yoshimoto T. Perioperative factors related to the development of ischemic complications in patients with moyamoya disease. Childs Nerv Syst. 1997 Feb;13(2):68-72.

Baykan N, Ozgen S, Ustalar ZS, et al. Moyamoya disease and anaesthesia: case report. Paediatr Anaesth 2005;15:1111–1115.

Gupta A, Gelb A, Duane D, et al (Eds.) (2013). Nöroanestezi ve Nöroyoğun Bakımın Esasları (Ülkü Aypar, Şennur Uzun Çev. Ed.) Ankara: Güneş Kitap Evi, 2013.

Zhang H, Zheng L, Feng L. Epidemiology, diagnosis and treatment of moyamoya disease. Exp Ther Med. 2019 Mar;17(3):1977-1984.

Hishikawa T, Sugiu K, Date I. Moyamoya Disease: A Review of Clinical Research. Acta Med Okayama. 2016 Aug;70(4):229-36.

Helander EM, Menard BL, Harmon CM, et al. Multimodal Analgesia, Current Concepts, and Acute Pain Considerations. Curr Pain Headache Rep. 2017 Jan;21(1):3. doi: 10.1007/s11916-017-0607-y.

Published

January 13, 2022

License

License